Cargando…
Towards a Clinically Relevant Lentiviral Transduction Protocol for Primary Human CD34(+) Hematopoietic Stem/Progenitor Cells
BACKGROUND: Hematopoietic stem cells (HSC), in particular mobilized peripheral blood stem cells, represent an attractive target for cell and gene therapy. Efficient gene delivery into these target cells without compromising self-renewal and multi-potency is crucial for the success of gene therapy. W...
Autores principales: | Millington, Michelle, Arndt, Allison, Boyd, Maureen, Applegate, Tanya, Shen, Sylvie |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714083/ https://www.ncbi.nlm.nih.gov/pubmed/19649289 http://dx.doi.org/10.1371/journal.pone.0006461 |
Ejemplares similares
-
Cassette deletion in multiple shRNA lentiviral vectors for HIV-1 and its impact on treatment success
por: Mcintyre, Glen J, et al.
Publicado: (2009) -
Staurosporine Increases Lentiviral Vector Transduction Efficiency of Human Hematopoietic Stem and Progenitor Cells
por: Lewis, Gretchen, et al.
Publicado: (2018) -
Lentiviral Transduction of CD34(+) Cells Induces Genome-Wide Epigenetic Modifications
por: Yamagata, Yoshiaki, et al.
Publicado: (2012) -
Decitabine Suspends Human CD34(+) Cell Differentiation and Proliferation during Lentiviral Transduction
por: Uchida, Naoya, et al.
Publicado: (2014) -
Lentiviral transduction of Tar Decoy and CCR5 ribozyme into CD34+ progenitor cells and derivation of HIV-1 resistant T cells and macrophages
por: Banerjea, Akhil, et al.
Publicado: (2004)